Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Patrick Spencer, RN, OCN

Advertisement

Articles by Patrick Spencer, RN, OCN

Patrick Spencer on Preparing Patients with Multiple Myeloma for Daratumumab Treatment

ByPatrick Spencer, RN, OCN
March 28th 2017

Patrick Spencer, RN, OCN provides important points to cover when counseling a patient with multiple myeloma receiving treatment with daratumumab.

Advertisement

Latest Updated Articles

  • Patrick Spencer on Preparing Patients with Multiple Myeloma for Daratumumab Treatment
    Patrick Spencer on Preparing Patients with Multiple Myeloma for Daratumumab Treatment

    March 28th 2017



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Daraxonrasib Approved: What Oncology Nurses Must Know About Rasonque

2

FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma

3

APAO 2026: Dr. Angela Jia on Navigating Data in Prostate and GU Cancer

4

Subcutaneous Dosing and Upfront Prophylaxis in EGFR-Mutated NSCLC

5

Navigating TNBC: Nurse-Led Insights on ADCs and Toxicity Management

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us